Karyopharm Therapeutics Inc. KPTI 41.36
Health Care · NASDAQ · Data as of 2026-08-13
Karyopharm Therapeutics Inc. (KPTI) has delivered +89.9% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1360 of 1968 stocks overall and #168 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
41.36
Overall Rank
#1360 / 1968
Sector Rank
#168 / 260
Revenue CAGR
+89.9%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio